The UC Davis Cancer Center received NCI designation
On Jul. 2, 2002, the University of California, Davis Comprehensive Cancer Center announced it had received National Cancer…
-
-
Biotechnology | Chemistry | Diagnostics | NIH | Oncology | Therapeutics
NCI scientists identified adult patients with non-Hodgkin’s lymphoma likely to be cured by chemotherapy
On Jun. 19, 2002, National Cancer Institute (NCI) scientists used microarray technology to determine the patterns of genes…
-
NCI researchers reported that the molecularly targeted drug bevacizumab slowed tumor growth in patients with metastatic renal cell carcinoma
On May 19, 2002, researchers from the National Cancer Institute reported that the molecularly targeted drug bevacizumab slowed…
-
Biotechnology | CDC | NIH | Oncology | Therapeutics | U.S. Congress
The Hematologic Cancer Research Investment and Education Act Signed into Law
On May 14, 2002, President George W. Bush signed the Hematologic Cancer Research Investment and Education Act of…
-
The International Genomics Consortium selected Phoenix for its headquarters
On May 14, 2002, the International Genomics Consortium (IGC) selected Phoenix for its headquarters. The mission of the…
-
Emory University established the Tobacco Technical Assistance Consortium
On Feb. 11, 2002, three leading national health organizations announced they had committed $15 million to establish the…
-
Scientists from NCI and FDA reported that patterns of proteins found in patients’ serum may reflect the presence of ovarian cancer
On Feb. 7, 2002, scientists from the National Cancer Institute (NCI) and the Food and Drug Administration (FDA)…
-
FDA approved Gleevec for gastrointestinal stromal tumors treatment
On Feb. 1, 2002, the U.S. Food and Drug Administration (FDA) approved the drug Gleevec, formerly known as…
-
Andrew C von Eschenbach became the twelfth director of the National Cancer Institute, serving until 2006
On Jan. 22, 2002, Dr. Andrew C. von Eschenbach became the twelfth director of the National Cancer Institute…
-
Biotechnology | Diagnostics | Disease | Medicine | Oncology | Therapeutics
The Cancer Center at Baylor College of Medicine was established
In 2002, the Cancer Center at Baylor College of Medicine, now known as the Dan L Duncan Comprehensive…
-
Biotechnology | Genomics | HIV | Oncology
Stanford researchers became the first to use RNAi to switch off genes in mice
In 2002, Stanford geneticist Mark Kay uses a gene-therapy technique known as RNA inhibition to switch off genes…
-
Stanford researchers became the first to use gene expression profiling to predict cancer outcomes
In 2002, Stanford researchers became the first to use gene expression profiling to predict cancer outcomes. The research…
-
The National Cancer Institute launched the National Lung Screening Trial
In 2002, the National Cancer Institute (NCI) launched the landmark National Lung Screening Trial (NLST) to determine whether…
-
Digital diagnostic technology developed with creation of AQUA (Automated Quantitative Analysis) at Yale Cancer Center
In 2002, digital diagnostic technology was developed with the creation of AQUA (Automated Quantitative Analysis) at Yale Cancer…
-
The Nevada Cancer Institute was founded
In 2002, the Nevada Cancer Institute (NVCI), founded in 2002 and located in Summerlin, was a non-profit organization…
-
$2.5 million award from Jeld-Wen Foundation endowed OHSU Chair in Leukemia Research for Brian Druker
On Nov. 7, 2001, the Oregon Health Sciences University Foundation (OHSU) announced that the Klamath Falls-based JELD-WEN Foundation…
-
Biotechnology | Diagnostics | NIH | Oncology | Therapeutics
The National Cancer Institute launched the Consumer Advocates in Research and Related Activities program
On Sept. 10, 2001, the National Cancer Institute (NCI) launched the Consumer Advocates in Research and Related Activities…
-
National Cancer Institute and ACRIN launched first multicenter study to compare digital mammography
On Sept. 4. 2001, the National Cancer Institute (NCI) and the American College of Radiology Imaging Network launched…
-
The Alvin J Siteman Cancer Center was named a NCI Designated Cancer Center
In August 2001, the Alvin J. Siteman Cancer Center was named an National Cancer Institute (NCI) -Designated Cancer…
-
OMRF researchers found that BRCA1 and BRCA2 genes may predict breast cancer risk in women
On May 24, 2001, Dr. Eldon Jupe and a team of Oklahoma Medical Research Foundation (OMRF) researchers found…
-
The FDA approved Gleevec, developed by OHSU, for treatment of chronic myeloid leukemia
On May 10, 2001, the U.S. Food and Drug Administration (FDA) approved Gleevec, the world’s first targeted cancer…
-
Seattle Genetics completed its IPO
On Mar. 7, 2001, Seattle Genetics launched its IPO and sold 7 million shares at $7 per share…
-
The Seattle Cancer Care Alliance opened its doors
On Jan. 19, 2001, the Seattle Cancer Care Alliance outpatient clinic opened, the final phase in a more…
-
Livermore National Lab announced partnership with BioLuminate to develop ‘Smart Probe’ for breast cancer detection
On Jan. 10, 2001, Livermore National Laboratory announced a partnership with BioLuminate to develop ‘Smart Probe’ tool for…
-
The drug imatinib mesylate (Gleevec) was shown to be effective against chronic myelogenous leukemia
In 2001, the drug imatinib mesylate (Gleevec) was shown in a clinical trial to be effective against chronic…
-
Moores Cancer Center at UC San Diego achieved NCI designated comprehensive cancer center status
In 1978, Moores Cancer Center (MCC) at UC San Diego achieved National Cancer Institute (NCI) designated comprehensive cancer…
-
Karmanos Institute and JP McCarthy Cord Stem Cell Bank founded
In 2001, The J.P. McCarthy Cord Stem Cell Bank at the Karmanos Cancer Institute was founded as a…
-
The University of Minnesota Cancer Center was founded
In 2001, the University of Minnesota Cancer Center, now known as the Masonic Cancer Center, was founded. It…
-
Holden Cancer Center awarded NCI Comprehensive Center designation
In 2001, the Holden Cancer Center at University of Iowa received National Cancer Institute (NCI) Comprehensive Center designation….
-
Biotechnology | Diagnostics | Disease | NIH | Oncology | Rare Disease | Therapeutics
The Stephenson Cancer Center was established
In 2001, the Stephenson Cancer Center was established. Located on the University of Oklahoma (OU) Health Sciences Center…
